ERBB2 and breast carcinoma: Whole saliva samples were collected from subjects confirmed with either breast or ovarian tumor by histopathology, including confirmation of hormone receptor (HR) status (ER/PR and HER2/neu) in breast cancer subjects using immunohistochemistry (IHC).